Zepp Health (NYSE:ZEPP) Issues Quarterly Earnings Results

Zepp Health (NYSE:ZEPP) issued its quarterly earnings data on Tuesday. The company reported ($0.07) earnings per share for the quarter, FiscalAI reports. The firm had revenue of $51.55 million for the quarter. Zepp Health had a negative return on equity of 15.00% and a negative net margin of 15.48%.

Zepp Health Trading Down 0.3%

Shares of NYSE ZEPP opened at $6.17 on Tuesday. The stock has a market cap of $90.62 million, a price-to-earnings ratio of -2.46 and a beta of 1.78. Zepp Health has a twelve month low of $2.25 and a twelve month high of $61.85. The company’s fifty day moving average is $11.93 and its 200-day moving average is $19.41. The company has a quick ratio of 0.77, a current ratio of 1.02 and a debt-to-equity ratio of 0.28.

Institutional Investors Weigh In On Zepp Health

Several institutional investors have recently added to or reduced their stakes in ZEPP. Public Employees Retirement System of Ohio increased its stake in Zepp Health by 61.4% in the 4th quarter. Public Employees Retirement System of Ohio now owns 1,514 shares of the company’s stock valued at $41,000 after buying an additional 576 shares during the last quarter. Osaic Holdings Inc. increased its stake in Zepp Health by 239.5% in the 4th quarter. Osaic Holdings Inc. now owns 8,285 shares of the company’s stock valued at $223,000 after buying an additional 5,845 shares during the last quarter. Dimensional Fund Advisors LP acquired a new stake in Zepp Health in the 4th quarter valued at $241,000. Oasis Management Co Ltd. acquired a new stake in Zepp Health in the 3rd quarter valued at $276,000. Finally, Capstone Capital Management Ltd acquired a new stake in Zepp Health in the 4th quarter valued at $298,000. 52.61% of the stock is owned by institutional investors.

Analysts Set New Price Targets

Separately, Fundamental Research set a $56.28 price target on shares of Zepp Health and gave the company a “buy” rating in a research note on Wednesday, April 22nd. One analyst has rated the stock with a Buy rating and one has assigned a Sell rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Hold” and an average price target of $56.28.

Zepp Health Company Profile

Zepp Health Corp is a technology company specializing in the design, development and sale of smart wearable devices and health management solutions. Through its flagship Amazfit brand and the Zepp software ecosystem, the company offers a range of products—including smartwatches, fitness bands, smart scales and health-oriented mobile applications—designed to track key biometric data such as heart rate, sleep patterns, blood oxygen levels and activity metrics. Zepp Health’s integrated platform enables users to monitor wellness and fitness goals while leveraging cloud-based analytics for personalized insights.

At the core of Zepp Health’s offering is its Zepp cloud platform, which aggregates and analyzes data collected from its hardware lineup.